Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.  

 .

Publicly-Held Company
CNPJ (Corporate Taxpayer’s ID) #60.746.948/0001-12

Notice to the Market

Indirect acquisition of 6.5% of the capital stock of Odontoprev S.A.

Banco Bradesco S.A. informs its shareholders, clients, employees and the market that:  

1.    Its indirect subsidiary Bradesco Saúde S.A. (Bradesco Saúde), holder of 43.5% of the total voting capital stock of Odontoprev S.A. (Odontoprev), signed, on this date, with Mr. Randal Luiz Zanetti (Mr. Randal), agreement that establishes the terms and conditions of a reorganization of their respective stakes in Odontoprev (Reorganization), which will result in the indirect acquisition, by Bradesco Saúde, and in the sale by Mr. Randal, of a stake representing 6.5% of the voting capital stock of Odontoprev;

2.    After the acquisition, Bradesco Saúde will hold approximately 50.01% of Odontoprev. In the context of Reorganization, Mr. Randal will hold a position on the Board of Executive Officers of Bradesco Seguros S.A.;

3.    The operation is subject to the approval of Central Bank of Brazil; and

4.    The Parties relied on the financial advice exclusive of Banco Bradesco BBI S.A.

Cidade de Deus, Osasco, SP, October 14, 2013

Banco Bradesco S.A.

Luiz Carlos Angelotti

Executive Managing Officer and

Investor Relations Office